167 related articles for article (PubMed ID: 27153547)
21. Protein kinase C alpha expression is inversely related to ER status in endometrial carcinoma: possible role in AP-1-mediated proliferation of ER-negative endometrial cancer.
Fournier DB; Chisamore M; Lurain JR; Rademaker AW; Jordan VC; Tonetti DA
Gynecol Oncol; 2001 Jun; 81(3):366-72. PubMed ID: 11371124
[TBL] [Abstract][Full Text] [Related]
22. ERRα metabolic nuclear receptor controls growth of colon cancer cells.
Bernatchez G; Giroux V; Lassalle T; Carpentier AC; Rivard N; Carrier JC
Carcinogenesis; 2013 Oct; 34(10):2253-61. PubMed ID: 23720198
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of estrogen receptor-alpha in the endometrial carcinoma cell line Ishikawa: inhibition of growth and angiogenic factors.
Ali SH; O'Donnell AL; Mohamed S; Mousa S; Dandona P
Gynecol Oncol; 2004 Dec; 95(3):637-45. PubMed ID: 15581976
[TBL] [Abstract][Full Text] [Related]
24. Dual targeting of estrogen receptor α and estrogen-related receptor α: a novel endocrine therapy for endometrial cancer.
Mao X; Dong B; Gao M; Ruan G; Huang M; Braicu EI; Sehouli J; Sun P
Onco Targets Ther; 2019; 12():6757-6767. PubMed ID: 31686835
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of endometrial carcinoma cell growth using antisense estrogen receptor oligodeoxyribonucleotides.
Taylor AH; al-Azzawi F; Pringle JH; Bell SC
Anticancer Res; 2002; 22(6C):3993-4003. PubMed ID: 12553024
[TBL] [Abstract][Full Text] [Related]
26. Estradiol mediates vasculoprotection via ERRα-dependent regulation of lipid and ROS metabolism in the endothelium.
Li H; Liu Z; Gou Y; Yu H; Siminelakis S; Wang S; Kong D; Zhou Y; Liu Z; Ding Y; Yao D
J Mol Cell Cardiol; 2015 Oct; 87():92-101. PubMed ID: 26271712
[TBL] [Abstract][Full Text] [Related]
27. miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer.
He Z; Xu H; Meng Y; Kuang Y
Biomed Pharmacother; 2017 Apr; 88():902-910. PubMed ID: 28178620
[TBL] [Abstract][Full Text] [Related]
28. Regulation of the vascular endothelial growth factor and growth by estrogen and antiestrogens through Efp in Ishikawa endometrial carcinoma cells.
Dai H; Zhang P; Zhao S; Zhang J; Wang B
Oncol Rep; 2009 Feb; 21(2):395-401. PubMed ID: 19148513
[TBL] [Abstract][Full Text] [Related]
29. ERRα Up-Regulates Invadopodia Formation by Targeting HMGCS1 to Promote Endometrial Cancer Invasion and Metastasis.
Tang S; Ma J; Su P; Lei H; Tong Y; Cai L; Xu S; Mao X; Sun P
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835419
[TBL] [Abstract][Full Text] [Related]
30. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
[TBL] [Abstract][Full Text] [Related]
31. Characterization of a selective inverse agonist for estrogen related receptor α as a potential agent for breast cancer.
Zhang L; Liu P; Chen H; Li Q; Chen L; Qi H; Shi X; Du Y
Eur J Pharmacol; 2016 Oct; 789():439-448. PubMed ID: 27498368
[TBL] [Abstract][Full Text] [Related]
32. Estrogen-related receptor α regulates osteoblast differentiation via Wnt/β-catenin signaling.
Auld KL; Berasi SP; Liu Y; Cain M; Zhang Y; Huard C; Fukayama S; Zhang J; Choe S; Zhong W; Bhat BM; Bhat RA; Brown EL; Martinez RV
J Mol Endocrinol; 2012 Apr; 48(2):177-91. PubMed ID: 22333182
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of ERRα inhibits angiogenesis in human umbilical vein endothelial cells through regulating VEGF production and PI3K/Akt/STAT3 signaling pathway.
Zhang LD; Chen L; Zhang M; Qi HJ; Chen L; Chen HF; Zhong MK; Shi XJ; Li QY
Eur J Pharmacol; 2015 Dec; 769():167-76. PubMed ID: 26586335
[TBL] [Abstract][Full Text] [Related]
34. Clinical implications of the expression of estrogen receptor-alpha and -beta in primary and metastatic lesions of uterine endometrial cancers.
Fujimoto J; Sakaguchi H; Aoki I; Toyoki H; Tamaya T
Oncology; 2002; 62(3):269-77. PubMed ID: 12065875
[TBL] [Abstract][Full Text] [Related]
35. Estrogen-related receptor alpha and cancer: axis of evil.
Ranhotra HS
J Recept Signal Transduct Res; 2015; 35(6):505-8. PubMed ID: 26446880
[TBL] [Abstract][Full Text] [Related]
36. Expression of protease activated receptor-2 related to angiogenesis in tumor advancement of uterine endometrial cancers.
Jahan I; Fujimoto J; Alam SM; Sato E; Sakaguchi H; Tamaya T
Oncol Rep; 2007 Feb; 17(2):345-50. PubMed ID: 17203172
[TBL] [Abstract][Full Text] [Related]
37. The metastasis-associated gene MTA3 is downregulated in advanced endometrioid adenocarcinomas.
Brüning A; Jückstock J; Blankenstein T; Makovitzky J; Kunze S; Mylonas I
Histol Histopathol; 2010 Nov; 25(11):1447-56. PubMed ID: 20865667
[TBL] [Abstract][Full Text] [Related]
38. Epidermal growth factor-induced signaling in breast cancer cells results in selective target gene activation by orphan nuclear receptor estrogen-related receptor alpha.
Barry JB; Giguère V
Cancer Res; 2005 Jul; 65(14):6120-9. PubMed ID: 16024613
[TBL] [Abstract][Full Text] [Related]
39. Interplay between estrogen-related receptor alpha (ERRalpha) and gamma (ERRgamma) on the regulation of ERRalpha gene expression.
Zhang Z; Teng CT
Mol Cell Endocrinol; 2007 Jan; 264(1-2):128-41. PubMed ID: 17157980
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of estrogen-related receptor alpha (ERRalpha) is a negative prognostic predictor in human prostate cancer.
Fujimura T; Takahashi S; Urano T; Kumagai J; Ogushi T; Horie-Inoue K; Ouchi Y; Kitamura T; Muramatsu M; Inoue S
Int J Cancer; 2007 Jun; 120(11):2325-30. PubMed ID: 17294452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
